SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-24-000144
Filing Date
2024-02-13
Accepted
2024-02-13 16:34:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 xers13ga2024.htm SC 13G/A 59098
  Complete submission text file 0000935836-24-000144.txt   60658
Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Subject) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93215 | Film No.: 24626676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)